| Nicholas Jeremy Cajacob, MD | |
|
1600 7th Ave South Mcwane 5604, Birmingham, AL 35249-1900 | |
| (205) 638-9918 | |
| Not Available |
| Full Name | Nicholas Jeremy Cajacob |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Gastroenterology |
| Location | 1600 7th Ave South Mcwane 5604, Birmingham, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346568664 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD.31444 (Alabama) | Secondary |
| 2080P0206X | Pediatrics - Pediatric Gastroenterology | MD.31444 (Alabama) | Primary |
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Intervention programmes are vitally needed to support Amazonian communities exposed to mercury contamination in Latin America, and children who are among those most affected by lead poisoning.
Immusoft Corporation, a Seattle-Wash.-based cell therapy company, announced today that the U.S. Food and Drug Administration (FDA) has granted it Rare Pediatric Disease Designation (RPDD) for Iduronicrin genleukocel-T, Immusoft's Sleeping Beauty transposon-engineered autologous plasmablasts for the expression and delivery of alpha-L-iduronidase (IDUA) to treat Mucopolysaccharidosis type I (MPS I).
Researchers at the University of Maryland School of Medicine have found a "nose within the nose," a unique olfactory system within the noses of mice that is able to "smell" hormones involved in regulating water and salt balance in the body.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc., U.S., announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) recommended that the FDA approve febuxostat for the treatment of hyperuricemia in patients with gout.
A clinical trial for a vaccine to protect against the novel coronavirus commenced this Monday in the U.S.. If successful, this could mean an end to the current global pandemic of COVID-19 infections, feel experts.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas Jeremy Cajacob, MD 1600 7th Ave South Mcwane 5604, Birmingham, AL 35249-1900 Ph: (205) 638-9918 | Nicholas Jeremy Cajacob, MD 1600 7th Ave South Mcwane 5604, Birmingham, AL 35249-1900 Ph: (205) 638-9918 |
News Archive
Intervention programmes are vitally needed to support Amazonian communities exposed to mercury contamination in Latin America, and children who are among those most affected by lead poisoning.
Immusoft Corporation, a Seattle-Wash.-based cell therapy company, announced today that the U.S. Food and Drug Administration (FDA) has granted it Rare Pediatric Disease Designation (RPDD) for Iduronicrin genleukocel-T, Immusoft's Sleeping Beauty transposon-engineered autologous plasmablasts for the expression and delivery of alpha-L-iduronidase (IDUA) to treat Mucopolysaccharidosis type I (MPS I).
Researchers at the University of Maryland School of Medicine have found a "nose within the nose," a unique olfactory system within the noses of mice that is able to "smell" hormones involved in regulating water and salt balance in the body.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc., U.S., announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) recommended that the FDA approve febuxostat for the treatment of hyperuricemia in patients with gout.
A clinical trial for a vaccine to protect against the novel coronavirus commenced this Monday in the U.S.. If successful, this could mean an end to the current global pandemic of COVID-19 infections, feel experts.
› Verified 3 days ago
Robert Patrick Richter, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1600 7th Ave S, Birmingham, AL 35233 Phone: 205-638-9100 | |
Dr. Mary Orr, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1600 7th Ave S, Birmingham, AL 35233 Phone: 205-638-9100 Fax: 205-934-7273 | |
Roger Dean Bruce, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2660 10th Ave S, Suite 636, Birmingham, AL 35205 Phone: 205-930-2220 Fax: 205-930-2223 | |
Stephanie Berger, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1600 7th Ave S, Mcwane Building Suite 108, Birmingham, AL 35233 Phone: 205-638-2904 | |
Jaime Dion Mckinney, Pediatrics Medicare: Medicare Enrolled Practice Location: 703 Volker Hl, Birmingham, AL 35294 Phone: 205-934-3795 | |
Worth Littlejohn Barbour, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-939-9587 | |
Timothy Todd Fleenor, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-5004 |